Literature DB >> 221925

Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution.

G Klein.   

Abstract

Human B cell lymphoma and murine T cell leukemia can be initiated by several agents. The present paper formulates some thoughts on the role of cytogenetic changes in the subsequent neoplastic process. Initiation creates long-lived preneoplastic cells. In some respects, they are comparable to in vitro-transformed ("immortalized") cell lines that maintain a diploid karyotype and are not tumorigenic in vivo. The development of a tumorigenic ("autonomous") clone is dependent on additional changes at the genetic level. In human B and murine T cell lymphoma, there are characteristic nonrandom chromosomal changes. The 14q+ marker appears to play a key role in human B cell lymphomas. The reciprocal 8;14 translocation in Burkitt lymphoma is a specialized subclass within this category. In murine T cell leukemia, trisomy 15 is the predominant change. The clustering of these nonrandom changes to tumors derived from a certain cell type rather than to tumors induced by a given etiological agent has important implications for the understanding of the genetic control of cellular responsiveness to growth-regulating forces in vivo.

Entities:  

Mesh:

Year:  1979        PMID: 221925      PMCID: PMC383618          DOI: 10.1073/pnas.76.5.2442

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  72 in total

1.  Association of Epstein-Barr viral genomes with American Burkitt lymphoma.

Authors:  M Andersson; G Klein; J L Zeigler; W Henle
Journal:  Nature       Date:  1976-03-25       Impact factor: 49.962

2.  EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.

Authors:  H zur Hausen; H Schulte-Holthausen; G Klein; W Henle; G Henle; P Clifford; L Santesson
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

3.  Cell fusion and the analysis of malignancy.

Authors:  H Harris
Journal:  Proc R Soc Lond B Biol Sci       Date:  1971-10-12

4.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

5.  Chromosomal control of malignancy in tumours from cells transformed by polyoma virus.

Authors:  T Yamamoto; M Hayashi; Z Rabinowitz; L Sachs
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.

Authors:  T Lindahl; G Klein; B M Reedman; B Johansson; S Singh
Journal:  Int J Cancer       Date:  1974-06-15       Impact factor: 7.396

7.  Marker band in one chromosome 14 from Burkitt lymphomas.

Authors:  G Manolov; Y Manolova
Journal:  Nature       Date:  1972-05-05       Impact factor: 49.962

8.  Foreign-cell contamination in Burkitt tumours.

Authors:  P J Fialkow; G Klein; E R Giblett; B Gothoskar; P Clifford
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

9.  The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives.

Authors:  G Klein; U Bregula; F Wiener; H Harris
Journal:  J Cell Sci       Date:  1971-05       Impact factor: 5.285

Review 10.  Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man.

Authors:  G Miller
Journal:  Yale J Biol Med       Date:  1971-06
View more
  55 in total

1.  Clonal analysis of the late stages of erythroleukemia induced by two distinct strains of Friend leukemia virus.

Authors:  D Mager; M E MacDonald; I B Robson; T W Mak; A Bernstein
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  Genetic mapping of the gene coding for the integrin beta 7 subunit to the distal part of mouse chromosome 15.

Authors:  Q Yuan; C A Kozak; W M Jiang; D Hollander; J D Watson; G W Krissansen
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  The cellular ecology of progressive neoplastic transformation: a clonal analysis.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Histiocytic Lymphoma in Renal Transplant Patients Receiving Cyclosporine.

Authors:  J T Rosenthal; S Iwatsuki; T E Starzl; R J Taylor; T R Hakala
Journal:  Transplant Proc       Date:  1983-12       Impact factor: 1.066

5.  Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells.

Authors:  N Bar-Eli; H Giloh; M Schlesinger; Z Zakay-Rones
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Chromosomal localization of the Epstein-Barr virus (EBV) genome in Bloom's syndrome B-lymphoblastoid cell lines transformed with EBV.

Authors:  Y Shiraishi; T Taguchi; Y Ohta; K Hirai
Journal:  Chromosoma       Date:  1985       Impact factor: 4.316

Review 7.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

Review 8.  Chemical carcinogenesis -- the price for DNA - repair?

Authors:  U Wintersberger
Journal:  Naturwissenschaften       Date:  1982-03

Review 9.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

10.  Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda.

Authors:  Lynnette K Tumwine; Claudio Agostinelli; Cristina Campidelli; Emmanuel Othieno; Henry Wabinga; Simona Righi; Brunangelo Falini; Pier Paolo Piccaluga; Wilson Byarugaba; Stefano A Pileri
Journal:  BMC Clin Pathol       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.